Clinical Trial Update: Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intracameral moxifloxacin for prevention of postcataract endophthalmitis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Endophthalmitis | Phase 3 | Status: TERMINATED